In vivo transfection of nuclear factor κB decoy protects pulmonary function against acute lung contusion in rabbits

Li Wan1, Huansen Huang, Danqing Fang

  • 1Departments of Anesthesia, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, People's Republic of China. wanli5000cn@yahoo.com.cn

Abstract

Insights

Inhibiting nuclear factor κB (NF-κB) with a decoy oligodeoxynucleotide improved respiratory function and reduced inflammatory markers after acute lung injury in rabbits. This suggests NF-κB inhibition may preserve pulmonary function in patients with acute lung injury.

Area of Science:

  • Pulmonary Medicine
  • Molecular Biology
  • Immunology

Background:

  • Nuclear factor κB (NF-κB) activation exacerbates inflammation following acute injury.
  • NF-κB regulates key proinflammatory mediators impacting acute lung injury.
  • Investigating NF-κB inhibition as a therapeutic strategy for lung contusion.

Purpose of the Study:

  • To evaluate the efficacy of an NF-κB decoy oligodeoxynucleotide in mitigating lung injury.
  • To assess the impact of NF-κB inhibition on proinflammatory cytokine expression.
  • To determine the effect on pulmonary function after acute lung contusion.

Main Methods:

  • Rabbits with acute lung contusion received NF-κB decoy or scrambled control oligodeoxynucleotide intravenously.
  • Blood gas analysis and serum cytokine levels (TNF-α, IL-1β, IL-10, IL-13) were measured.
  • NF-κB protein expression in lung tissue was assessed via Western blot.

Main Results:

  • NF-κB decoy injection improved blood oxygenation and respiratory function post-contusion.
  • Decoy treatment significantly reduced NF-κB protein expression and serum levels of TNF-α and IL-1β.
  • Anti-inflammatory cytokines IL-10 and IL-13 showed increased serum levels after decoy administration.

Conclusions:

  • An NF-κB decoy oligodeoxynucleotide protected respiratory function in a rabbit model of lung contusion.
  • NF-κB inhibition reduced pro-inflammatory cytokine secretion and enhanced anti-inflammatory responses.
  • Targeting NF-κB offers a potential therapeutic approach for preserving pulmonary function in acute lung injury.